All Posts Tagged Tag: ‘Gilead Sciences’

HIV Treatment Approved by the FDA

Gilead Sciences, a biotech research company, announced today that its new HIV treatment drug has been approved by the U.S. Food and Drug Administration. Dubbed Stribild, the once-daily tablet is made up of four different compounds and designed for those not currently taking medication for HIV. “Over the past decade, co-formulated HIV medicines have simplified therapy for many patients and …

Read More